Atlas Trials

Pirtobrutinib, Lisaftoclax, and Rituximab in the Treatment of R/R DLBCL

Clinical trial NCT07255963 · RECRUITING

Trial details

NCT number
NCT07255963
Sponsor
The First Affiliated Hospital of Soochow University
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
DLBCL - Diffuse Large B Cell Lymphoma
Start date
2025-11-30
Primary completion
2028-09-30
Enrollment
29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.